Epinex Diagnostics’s Patent Granted for Diabetes Test
The United States Patent and Trademark Office (USPTO) granted Epinex Diagnostics the patent for its primary technology, the G1A? Rapid Diabetes Monitoring Index Test.
Read MorePosted by Clinical Lab Products | Mar 3, 2010 | Diabetes & Metabolic Diseases |
The United States Patent and Trademark Office (USPTO) granted Epinex Diagnostics the patent for its primary technology, the G1A? Rapid Diabetes Monitoring Index Test.
Read MorePosted by Clinical Lab Products | Mar 1, 2010 | Cancer, Miscellaneous |
Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this months Gastroenterology.
Read MorePosted by Clinical Lab Products | Feb 5, 2010 | Cancer, Miscellaneous |
OraSure and Roche Sign Commercialization Agreement for Oral Fluid DOA Assays OraSure Technologies Inc and Roche Diagnostics announced that the companies have signed an agreement for the worldwide commercialization of homogeneous fully automated
Read MorePosted by Clinical Lab Products | Jan 7, 2010 | Miscellaneous |
ADA Recommends A1C as Diagnostic Test for Diabetes The American Diabetes Association‘s new Clinical Practice Recommendations being published as a supplement to the January issue of Diabetes Care call for the addition of the A1C test as a means o
Read MorePosted by Clinical Lab Products | Jan 5, 2010 | Miscellaneous |
Without a doubt, the top story of 2009 was the emergence of H1N1/swine flu and the ensuing international pandemic. An influenza pandemic had been anticipated for some time, and the response to the appearance of H1N1 has been truly impressiv
Read More